UTHR logo

UTHR
United Therapeutics Corp

2,501
Mkt Cap
$24.86B
Volume
301,756.00
52W High
$607.89
52W Low
$272.12
PE Ratio
20.33
UTHR Fundamentals
Price
$567.16
Prev Close
$572.85
Open
$572.70
50D MA
$534.74
Beta
0.45
Avg. Volume
702,386.43
EPS (Annual)
$27.86
P/B
3.49
Rev/Employee
$2.27M
$20,418.98
Loading...
Loading...
News
all
press releases
United Therapeutics Corporation $UTHR Shares Sold by Polaris Capital Management LLC
Polaris Capital Management LLC trimmed its position in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 15.1% in the fourth quarter, according to the company in its most...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
United Therapeutics (NASDAQ:UTHR) CFO Sells $5,513,815.56 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 9,636 shares of United Therapeutics stock in a transaction on Thursday, April 23rd. The stock was sold at an...
MarketBeat·1d ago
News Placeholder
Insider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 2,910 Shares of Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) Director Christopher Patusky sold 2,910 shares of the business's stock in a transaction dated Friday, April 24th. The stock was sold at...
MarketBeat·1d ago
News Placeholder
Insider Selling: United Therapeutics (NASDAQ:UTHR) CFO Sells 364 Shares of Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 364 shares of the company's stock in a transaction on Wednesday, April 22nd. The stock was sold at an average...
MarketBeat·1d ago
News Placeholder
China Universal Asset Management Co. Ltd. Reduces Position in United Therapeutics Corporation $UTHR
China Universal Asset Management Co. Ltd. lessened its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 24.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,516 shares of the bi...
MarketBeat·2d ago
News Placeholder
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business's stock in a transaction that occurred on Wednesday, April 22nd. The stock was...
MarketBeat·2d ago
News Placeholder
United Therapeutics (UTHR) to Report Q1 Results: Wall Street Expects Earnings Growth
United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·4d ago
News Placeholder
Zurcher Kantonalbank Zurich Cantonalbank Purchases 32,689 Shares of United Therapeutics Corporation $UTHR
Zurcher Kantonalbank Zurich Cantonalbank boosted its position in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 169.2% during the fourth quarter, according to the company in its most...
MarketBeat·4d ago
News Placeholder
United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2026 financial results in a press release that will be issued on Wednesday, May 6, 2026 at...
Business Wire·4d ago
News Placeholder
Novem Group Makes New $1.09 Million Investment in United Therapeutics Corporation $UTHR
Novem Group acquired a new stake in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·4d ago
<
1
2
...
>

Latest UTHR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.